XML 36 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Restructuring
12 Months Ended
Sep. 30, 2023
Restructuring and Related Activities [Abstract]  
Restructuring

12. Restructuring

In the second quarter of fiscal 2023, we initiated a spending reduction plan intended to preserve capital and more closely align our capital allocation priorities with our strategic objectives, which included a workforce restructuring in our Medical Device segment. As a result, in fiscal 2023, we recorded $1.3 million in severance and related charges in restructuring expense on our consolidated statements of operations. All associated expenses have been paid as of September 30, 2023.